Ellicott City, MD, United States of America

David Burgenson


Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Bioprocessing: The Contributions of David Burgenson

Introduction

David Burgenson is an accomplished inventor based in Ellicott City, MD. He has made significant contributions to the field of bioprocessing, particularly in the area of protein manufacturing. With a total of two patents to his name, Burgenson's work focuses on developing systems that enhance the production and delivery of therapeutic proteins.

Latest Patents

Burgenson's latest patents include a "Microscale bioprocessing system and method for protein manufacturing from human blood." This innovative system is designed to be compact and integrated, allowing for on-demand production and delivery of therapeutic proteins directly to patients. The system utilizes the patient's own blood as the source of cell extracts for producing these proteins. Another notable patent is the "System and method for production of on-demand proteins in a portable unit for point of care delivery." This portable bioprocessing system is also compact and integrated, enabling efficient on-demand production of various proteins for immediate delivery to patients or for assay purposes.

Career Highlights

Burgenson is affiliated with the University System of Maryland, where he continues to advance his research and development efforts in bioprocessing technologies. His work is pivotal in addressing the growing need for accessible and efficient protein manufacturing solutions.

Collaborations

Burgenson collaborates with notable colleagues such as Govind Rao and Yordan Kostov, contributing to a dynamic research environment that fosters innovation in bioprocessing.

Conclusion

David Burgenson's contributions to the field of bioprocessing exemplify the potential of innovative technologies in healthcare. His patents reflect a commitment to improving patient care through advanced protein manufacturing systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…